Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Camp Lejeune Cases
  • Drug Injury
  • Free Case Evaluation
  • About Us

Ocaliva-related Liver Injury Warnings Will be Added to Ocaliva Drug Label

June 1, 2021 By Law Offices of Thomas J. Lamb, P.A.

We now know more about the Ocaliva-related liver injury “safety signal” that the FDA has been investigating over the past year, and as a result of that Ocaliva FDA safety evaluation there will be an Ocaliva label change with new warnings. On May 26, 2021, this FDA Drug Safety Communication about Ocaliva, “Due to risk of serious liver injury, FDA … [Read more...]

Filed Under: Unsafe Drugs Tagged With: drug-induced liver injury, liver damage, liver failure, liver injury, liver transplants, Ocaliva

Guidelines for Diagnosing and Managing Patients with Drug-induced Liver Injury

May 10, 2021 By Law Offices of Thomas J. Lamb, P.A.

We continue to monitor the medical literature for developments relevant to the important drug safety issue of drug-induced liver injury (DILI). This medical journal article, “ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury”, appeared in The American Journal of Gastroenterology (AJC) May 2021 … [Read more...]

Filed Under: Unsafe Drugs Tagged With: drug-induced liver injury, liver injury

Gilenya Label Change with New Liver Injury Risk Warnings in Canada

January 22, 2021 By Law Offices of Thomas J. Lamb, P.A.

In the final two months of 2020, we saw a Gilenya label change adding new liver risk warnings announced by drug regulators in Europe, first, and the United Kingdom (UK), later.  Next, in January 2021, Health Canada posted a Gilenya drug safety alert about patients developing Gilenya-associated liver injury, including acute liver failure … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Gilenya, liver failure, liver injury

Gilenya Linked To Acute Liver Failure, Drug-induced Liver Injury

November 13, 2020 By Law Offices of Thomas J. Lamb, P.A.

As reported in this European Medicines Agency (EMA) periodic safety update report, “Gilenya (fingolimod): Updated recommendations to minimise the risk of drug-induced liver injury (DILI)”, published November 10, 2020, there have been cases of Gilenya-related liver failure and drug-induced liver injury associated with Gilenya. A Direct Healthcare … [Read more...]

Filed Under: Unsafe Drugs Tagged With: drug-induced liver injury, Gilenya, liver failure, liver injury

Ocaliva Drug Label Warnings vis-à-vis FDA Ocaliva Safety Signal Investigation

October 19, 2020 By Law Offices of Thomas J. Lamb, P.A.

In our last article, we reported on the current FDA investigation of an Ocaliva safety signal which, although it began in May 2020, only became public knowledge in October. The best we can tell, it is a possible Ocaliva liver toxicity issue that is the subject of this Ocaliva FDA investigation. Now we have some additional information about some … [Read more...]

Filed Under: Unsafe Drugs Tagged With: liver damage, liver failure, liver injury, Ocaliva

Current Ocaliva Liver Safety FDA Evaluation Started Back in May 2020

October 15, 2020 By Law Offices of Thomas J. Lamb, P.A.

In October 2020 we first learned about a "new" drug safety issue for Ocaliva -- although it apparently has been on the FDA's radar since at least May 2020. It seems a possible Ocaliva liver-related side effects risk has attracted scrutiny, and there is an Ocaliva liver safety FDA evaluation underway. It was this October 9, 2020, Endpoints News … [Read more...]

Filed Under: Unsafe Drugs Tagged With: drug-induced liver injury, liver damage, liver failure, liver injury, Ocaliva

Actemra Liver Injury Risks Warnings Added To Drug Label In June 2019

June 18, 2019 By Law Offices of Thomas J. Lamb, P.A.

The FDA sent an email on June 13, 2019 about Drug Safety-related Labeling Changes (SrLC) which alerted us to a revised version of the Actemra Prescribing Information document used in the US. Upon review of this new section added to the “Warnings and Precautions” part of the June 2019 Actemra drug label (accessed 6/13/19): 5.3 … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Actemra, drug-induced liver injury, liver injury, liver transplants

Pradaxa Liver Injury: Label Changes Warning About This Increased Risk

July 27, 2018 By Law Offices of Thomas J. Lamb, P.A.

We are watching to see whether the FDA and/or European drug regulators require a Pradaxa liver injury label change adding a new warning about an increased risk of acute liver failure and drug-induced hepatitis — like what was done in Japan last year and is being done now in Canada. In May 2018 Health Canada announced that their Pradaxa drug … [Read more...]

Filed Under: Unsafe Drugs Tagged With: drug side effects, drug-induced liver injury, liver damage, liver failure, liver injury, Pradaxa

Uterine Fibroid Drug Esmya Investigated Due to Severe Liver Injuries

February 22, 2018 By Law Offices of Thomas J. Lamb, P.A.

About Esmya Esmya (ulipristal acetate) is indicated for the treatment of severe symptoms caused by uterine fibroids -- or noncancerous growths in the uterus -- in women of reproductive age. While Esmya is currently available in Europe, it is still pending FDA approval in the U.S. The active ingredient, ulipristal acetate is the same as that … [Read more...]

Filed Under: Unsafe Drugs Tagged With: EMA, esmya, esmya side effects, European Medicines Agency, hepatic failure, liver failure, liver injury, liver transplants, Pharmacovigilance Risk Assessment Committee, PRAC, ulipristal acetate, uterine fibroids treatments

Ocaliva Patients Died From Liver Injury Says September 2017 FDA Report

October 5, 2017 By Law Offices of Thomas J. Lamb, P.A.

A liver side effects issue for Ocaliva was presented in this document, “FDA Drug Safety Communication: FDA warns about serious liver injury with Ocaliva (obeticholic acid) for rare chronic chronic liver disease”, issued on September 21, 2017. From the Safety Announcement part of that document: The Food and Drug Administration (FDA) is warning … [Read more...]

Filed Under: Unsafe Drugs Tagged With: liver damage, liver failure, liver injury, Ocaliva

  • 1
  • 2
  • Next Page »

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • PFAS Firefighter Gear Lawsuits
  • Camp Lejeune Cases
  • GenX Water Cancer Cases
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Philips Breathing Devices Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.